Managing High Dose Sufentanil in a Suffering Patient

References 

1. Gauthier ME, Fine PG. The emerging role of the fentanyl series in the treatment of chronic cancer pain. In:  Portenoy RK,  Bruera E editor. Topics in palliative care. New York: Oxford University Press; 1997;p. 177–194
2. Reynolds L, Rauck R, Webster L, et al. Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain. Pain. 2004;110:182–188
   • Abstract
   • Full Text
   • Full-Text PDF (128 KB)
   • CrossRef
3. Kampe S, Randerbrock G, Kiencke P, et al. Comparison of continuous epidural infusion of ropivacaine and sufentanil with intravenous patient-controlled analgesia after total hip replacement. Anaesthesia. 2001;52:1189–1193
4. Nelson KE, Rauch T, Terebub V, et al. A comparison of intrathecal fentanyl and sufentanil for labor analgesia. Anesthesiology. 2002;96:1070–1073
   • MEDLINE
   • CrossRef
5. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. J Clin Oncol. 1998;16:3216–3221
   • MEDLINE
6. Janssen PAJ. Opioids in analgesia. In:  Estafanous FG editors. The development of new synthetic narcotics. Boston, MA: Butterworth; 1984;p. 40
7. Bailey PL, Stanley TH. Narcotic intravenous anesthetics. In:  Miller RD editors. Anesthesia. 3rd ed.. New York: Churchill Livingstone; 1990;pp. 281–366
8. Paix A, Coleman A, Lees J, et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 63:263–269.